Publication Opportunities
Publication Opportunities
- Publication in the Journals
Participants in this conference are cordially invited to contribute a full manuscript to the conference's Topic New Drugs and Combinations in the Management of Hematological Malignancies and Rare Diseases, published jointly by Hematology Reports (ISSN 2038-8330, Impact Factor 1.9), Hemato (ISSN 2673-6357, Impact Factor 0.7), and Thalassemia Reports (ISSN 2039-4365, Impact Factor 2.4) with a 20% discount on the publication fee. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper. - Proceeding Paper Publication
All accepted abstracts will be published in the conference report of IOCHE2026 in Medical Life Sciences Forum (ISSN 2673-9992); authors of accepted abstracts are highly encouraged to submit an extended proceeding paper (ideally 4-8 pages in length) for free. Please submit it to the same journal after the conference.
Authors are asked to disclose that it is a proceeding paper of the IOCHE2026 conference in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings paper submission deadline: 14 December 2026.
Manuscripts for the proceedings issue must be formatted as follows:
Title;
Full author names;
Affiliations (including full postal address) and authors' e-mail addresses;
Abstract;
Keywords;
Introduction;
Methods;
Results and Discussion;
Conclusions;
Acknowledgements;
References.
Please click HERE to submit your proceeding paper to the Medical Sciences Forum, and be sure to disclose the conference information in your cover letter or mention the conference name in your submission.
IOCHE2026-Proceedings-Template